Role of Nrf2/HO-1 and cytoglobin signaling in the protective effect of indole-3-acetic acid and chenodeoxycholic acid against kidney injury induced by valproate
Ahlam M. Alhusaini, Wedad Sarawi, Noor Mukhtar, Danah Aljubeiri, Amjad S. Aljarboa, Hessa Alduhailan, Faris Almutairi, Raeesa Mohammad, Muhammad Atteya, Iman Hasan · 2024
Read Role of Nrf2/HO-1 and cytoglobin signaling in the protective effect of indole-3-acetic acid and chenodeoxycholic acid against kidney injury induced by valproate by Ahlam M. Alhusaini, Wedad Sarawi, Noor Mukhtar, Danah Aljubeiri, Amjad S. Aljarboa, Hessa Alduhailan, Faris Almutairi, Raeesa Mohammad, Muhammad Atteya, Iman Hasan (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11697546.txt.
Description
Ahlam Alhusaini and co-authors test two compounds against kidney damage from the epilepsy drug valproate in rats in a 2024 study. Long valproate use can injure kidneys, but the pathway was not fully mapped. The team focused on a protective signaling route involving a master antioxidant switch and a stress protein it controls.
Rats given valproate for three weeks lost kidney antioxidants and gained markers of oxidative damage and inflammation. Adding either indole-3-acetic acid or a bile acid one hour after each dose blunted those changes across biochemical, tissue, and staining measures. The protective route's signals were part of the story the authors track. The work nominates both compounds as candidate shields, pending much more testing before any human use.
Catalog record
| CREATOR | Ahlam M. Alhusaini, Wedad Sarawi, Noor Mukhtar, Danah Aljubeiri, Amjad S. Aljarboa, Hessa Alduhailan, Faris Almutairi, Raeesa Mohammad, Muhammad Atteya, Iman Hasan |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 32 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |